83
Participants
Start Date
September 28, 2020
Primary Completion Date
March 8, 2023
Study Completion Date
March 8, 2023
Tiragolumab
Tiragolumab 840 milligrams (mg) administered by intravenous (IV) infusion on Day 1 of every 28-day cycle.
Atezolizumab
Atezolizumab 1680 mg administered by IV infusion on Day 1 of every 28-day cycle.
Nab-paclitaxel
Nab-paclitaxel 100 milligrams per square meter (mg/m\^2) administered by IV infusion on Days 1, 8, and 15 of every 28-day cycle.
Tiragolumab
Tiragolumab 420 mg administered by IV infusion Q2W.
Atezolizumab
Atezolizumab 840 mg administered by IV infusion Q2W.
Nab-paclitaxel
Nab-paclitaxel 125 mg/m\^2 administered by IV infusion QW.
Carboplatin
Carboplatin (area under the concentration-time curve \[AUC\]: 5 milligrams per milliliter per minute \[mg/mL/min\]) administered by IV infusion Q3W.
Doxorubicin
Doxorubicin 60 mg/m\^2 Q2W administered by IV infusion.
Cyclophosphamide
Cyclophosphamide 600 mg/m\^2 Q2W administered by IV infusion.
Granulocyte colony-stimulating factor (G-CSF)
G-CSF support for four doses.
Granulocyte-macrophage colony-stimulating factor (GM-CSF)
GM-CSF support for four doses.
National Taiwan Uni Hospital; General Surgery, Taipei
China Medical University Hospital; Surgery, Taichung
Mater Hospital; Cancer Services, South Brisbane
Fiona Stanley Hospital; FSH Cancer Centre Clinical Trials Unit, Bull Creek
Magee-Woman's Hospital, Pittsburgh
Complejo Hospitalario Universitario de Santiago (CHUS) ; Servicio de Oncologia, Santiago de Compostela
Levine Cancer Institute, Charlotte
Tennessee Onc., PLLC - SCRI, Nashville
Hospital Universitario Virgen Macarena; Servicio de Oncologia, Seville
Klinikum Essen-Mitte Ev. Huyssens-Stiftung / Knappschafts GmbH; Klinik für Senologie / Brustzentrum, Essen
Hospital Clínico Universitario de Valencia; Servicio de Oncología, Valencia
Univ of Chicago, Chicago
Nationales Centrum für Tumorerkrankungen (NCT) ; Gyn. Onk. Frauenklinik; Uniklinikum Heidelberg, Heidelberg
"SBIH Moscow Clinical Scientific and Practical Center named after A.S. Loginov of DHM", Moskva
Blokhin Cancer Research Center; Combined Treatment, Moskva
Arkhangelsk Regional Clinical Oncology Dispensary, Arkhangelsk
University of Alabama at Birmingham, Birmingham
Hospital Sao Rafael - HSR, Salvador
Hospital Araujo Jorge; Departamento de Ginecologia E Mama, Goiânia
Hospital Sírio-Libanês, São Paulo
Clinica de Pesquisa e Centro de Estudos em Oncologia Ginecologica e Mamaria Ltda, São Paulo
Severance Hospital, Yonsei University Health System, Seoul
Seoul National University Hospital, Seoul
Asan Medical Center, Seoul
Hoffmann-La Roche
INDUSTRY